[Na+,K(+)-ATPase as an object of the action of cardiotropic agents].
作者信息
Chekman I S, Samilova R D, Grinevich A I
出版信息
Eksp Klin Farmakol. 1992 Mar-Apr;55(2):65-8.
PMID:1330146
Abstract
摘要
相似文献
1
[Na+,K(+)-ATPase as an object of the action of cardiotropic agents].[钠钾ATP酶作为强心剂作用的靶点]
Eksp Klin Farmakol. 1992 Mar-Apr;55(2):65-8.
2
[Na+,K+-ATPase as a receptor of exogenous and endogenous cardiac glycosides].
Farmakol Toksikol. 1988 May-Jun;51(3):116-8.
3
4
The influence of protein tyrosine phosphatase-1B on Na,K-ATPase activity in lens.蛋白酪氨酸磷酸酶-1B对晶状体中钠钾ATP酶活性的影响。
J Cell Physiol. 2004 Sep;200(3):370-6. doi: 10.1002/jcp.20029.
5
Cryptosin induces backbone structural changes in cardiac Na+ and K+ dependent adenosinetriphosphatase.隐丹参酮诱导心脏钠钾依赖三磷酸腺苷酶的主链结构变化。
Biochem Int. 1990 Oct;22(2):287-94.
6
[The effect of cardiac glycosides and electrolytes on cell membrane sodium, potassium-adenosine triphosphatase].[强心苷和电解质对细胞膜钠、钾 - 三磷酸腺苷酶的影响]
J S Afr Vet Assoc. 1981 Sep;52(3):225-8.
7
Leucine 332 at the boundary between the fourth transmembrane segment and the cytoplasmic domain of Na+,K+-ATPase plays a pivotal role in the ion translocating conformational changes.位于钠钾ATP酶第四跨膜段与胞质结构域交界处的亮氨酸332在离子转运构象变化中起关键作用。
Biochemistry. 1997 Oct 28;36(43):13312-24. doi: 10.1021/bi971030q.
8
Role of the Na+K+-ATPase in the cardiotonic action of cardiac glycosides.钠钾ATP酶在强心苷类药物强心作用中的作用。
Prog Clin Biol Res. 1988;268B:321-38.
9
The sodium, potassium-pump.钠钾泵
Scand J Clin Lab Invest Suppl. 1986;180:11-23.
10
[Metabolism of magnesium and its role in the mechanism of action of cardiovascular agents (review of the literature)].[镁的代谢及其在心血管药物作用机制中的作用（文献综述）]
Farmakol Toksikol. 1981 Nov-Dec;44(6):743-8.
Zotero 插件